Fig. 1From: Tamoxifen in Duchenne muscular dystrophy (TAMDMD): study protocol for a multicenter, randomized, placebo-controlled, double-blind phase 3 trialFlow chart showing the study design of the placebo-controlled, double-blind phase of the tamoxifen in Duchenne muscular dystrophy (TAMDMD) study. *For those patients who do not enter the open-label extension phase. RCT randomized controlled trial, V visitBack to article page